Chugai Pharmaceutical Co., Ltd. announced today that the Company resolved at the meeting of its Board of Directors held today to distribute retained earnings with the record date being December 31, 2019, as described below.

This matter will be submitted to the 109th Annual General Meeting of Shareholders scheduled to be held on March 30, 2020.

Reasons for the Revision

Regarding income distribution, taking into account the strategic funding needs and earnings prospects, Chugai aims for a consolidated dividend payout ratio of 50% on average in comparison with Core EPS to provide a stable allocation of profit to all shareholders. In addition, internal reserves will be used to increase corporate value through investments to attain further growth in existing strategic domains and to identify future business opportunities.

In the fiscal year ended December 31, 2019, the Company achieved the highest results in the past and increased Core EPS by 73.3% year-on-year.

Reflecting the favorable results and based on our principles of 'aiming a consolidated dividend payout ratio of 50% on average in comparison with Core EPS to provide a stable allocation of profit,' year-end dividend for the fiscal year ended December 31, 2019 is planned to be JPY92 per share, which is sum of JPY48 as regular dividend and JPY44 as special dividend. As a result, total dividend for the fiscal year under review will be JPY140 per share, and the Core dividend payout ratio is 45.8% (an average of 47.4% for the past five years).

Contact:

Tomoko Shimizu

Tel: +81-3-3273-0881

Email: pr@chugai-pharm.co.jp

(C) 2020 Electronic News Publishing, source ENP Newswire